The European Commission and European Federation of Pharmaceutical Industries (EFPIA) formed a public-private partnership and began to implementing the Innovative Medicine Initiative (IMI).
The overall objective of this project is to facilitate the development of new medicine. IMI has a budget of Euro 2 billions until 2013.
In 2008 grants amounting to €123 million will be handled to the most promising research projects in the areas of brain disorders, metabolic and inflammatory disease. In future calls cancer and infectious disease would also be covered.
Further information together with calls for proposals kindly visit www.imi.europa.eu
Source: Funding at FME